Stephen Rundlett

Stephen Rundlett is currently the VP of Bioanalytical Services at Precision For Medicine. Prior to this, they were the Scientific Director of Bioanalysis and Biomarker Programs at Intertek Pharmaceutical Services from October 2017 to February 2020. Before that, they were the Senior Director of Business Development at Eurofins Bioanalytical Services from April 2012 to August 2017.

Rundlett's experience in the field began as a Technology Manager for Flow Cytometry and Luminex Assays at EMD Millipore from June 2007 to April 2012. Stephen then became a Product Manager at Gentra Systems from May 2005 to October 2006. In January 1998, they started at Athersys Inc as a Group Leader for Protein Chemistry and held that position until January 2003. Finally, they were a Postdoctoral Fellow at UCLA from May 1993 to December 1997.

Stephen Rundlett has a Ph.D. in Molecular and Cellular Biology from the University of Arizona, and a B.A. in Chemistry from California State University, Northridge.

Their manager is Chad Clark, President. Stephen Rundlett works with Jay Lezcano - SVP, Business Development, Rachel Owen - VP, Immunology, and Tobias Guennel - SVP, Global Translational Data Services.